{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:25:21Z","timestamp":1773285921787,"version":"3.50.1"},"reference-count":28,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":3459,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To examine the performance of current screening recommendations for detecting dysglycemia in children and adolescents with obesity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>In a cross-sectional study, an oral glucose tolerance test and demographic (age, sex, family history of diabetes, and ethnicity), clinical (BMI z score, waist circumference, and pubertal stage), and laboratory variables used in current pediatric screening criteria for type 2 diabetes mellitus were measured in 259 overweight or obese youth aged 5\u201317 years. Glycemic status was based on American Diabetes Association (ADA) thresholds. The performance (sensitivity and specificity) of current screening criteria and newly developed models to identify isolated IGT were compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Dysglycemia was present in 20.8% of the cohort. Of the 54 participants with dysglycemia, 68% had a normal fasting glucose and were identified with the 2-h glucose test. Current ADA criteria had low sensitivity (41.7% [95% CI 25.6\u201357.8]) and moderate specificity (69.5% [63.5\u201375.6]) to identify IGT. In receiver operating characteristic (ROC) analysis, the addition of hemoglobin A1c (HbA1c) or FPG did not improve the ROC area under the curve (AUC) (HbA1c: 0.64 vs. 0.63; P = 0.54; HbA1c + FPG: 0.66; P = 0.42), but adding triglyceride level did (AUC 0.72 vs. 0.63; P = 0.03). A simple model with fasting triglyceride level &amp;gt;1.17 mmol\/L improved AUC compared with ADA screening criteria (0.68 vs. 0.57; P = 0.04).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The prevalence of IGT is high among obese children and youth. Current screening criteria have low sensitivity to detect isolated IGT. Although adding nonfasting laboratory values to history and physical measures does not improve diagnostic accuracy, adding fasting lipid profile improves predictive value.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc11-1659","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T07:18:11Z","timestamp":1327389491000},"page":"711-716","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":21,"title":["Screening for Dysglycemia in Overweight Youth Presenting for Weight Management"],"prefix":"10.2337","volume":"35","author":[{"given":"Katherine M.","family":"Morrison","sequence":"first","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Xu","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Tarnopolsky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaheera","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"2022031302295616700_B1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2337\/diacare.28.4.902","article-title":"Predictors of changes in glucose tolerance status in obese youth","volume":"28","author":"Weiss","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031302295616700_B2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJMoa012578","article-title":"Prevalence of impaired glucose tolerance among children and adolescents with marked obesity","volume":"346","author":"Sinha","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031302295616700_B3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/oby.2009.355","article-title":"Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents","volume":"18","author":"Maffeis","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"2022031302295616700_B4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1399-5448.2008.00492.x","article-title":"Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: a simple risk score to identify children at risk for prediabetes","volume":"10","author":"Reinehr","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"2022031302295616700_B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1464-5491.2007.02380.x","article-title":"Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity","volume":"25","author":"Sabin","year":"2008","journal-title":"Diabet Med"},{"key":"2022031302295616700_B6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031302295616700_B7","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2337\/diacare.26.10.2910","article-title":"Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up","volume":"26","author":"Qiao","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031302295616700_B8","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"2022031302295616700_B9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031302295616700_B10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031302295616700_B11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/dc06-2089","article-title":"An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes","volume":"30","author":"Schulze","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031302295616700_B12","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031302295616700_B13","first-page":"S162","article-title":"Type 2 diabetes in children and adolescents. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada.","volume":"32","author":"Sellers","year":"2008","journal-title":"Can J Diabetes"},{"key":"2022031302295616700_B14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1542\/peds.105.3.671","article-title":"Type 2 diabetes in children and adolescents","volume":"105","author":"American Diabetes Association","year":"2000","journal-title":"Pediatrics"},{"key":"2022031302295616700_B15","unstructured":"Centers for Disease Control and Prevention. Epi Info program [software tool online], 2008. Available from http:\/\/www.cdc.gov\/epiinfo\/. Accessed 13 June 2008"},{"key":"2022031302295616700_B16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jpeds.2004.06.044","article-title":"Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents","volume":"145","author":"Fern\u00e1ndez","year":"2004","journal-title":"J Pediatr"},{"key":"2022031302295616700_B17","first-page":"7","article-title":"Fitness of Canadian children and youth: results from the 2007-2009 Canadian Health Measures Survey","volume":"21","author":"Tremblay","year":"2010","journal-title":"Health Rep"},{"key":"2022031302295616700_B18"},{"key":"2022031302295616700_B19"},{"key":"2022031302295616700_B20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2307\/1130220","article-title":"Validity of self-report measures of girls\u2019 pubertal status","volume":"58","author":"Brooks-Gunn","year":"1987","journal-title":"Child Dev"},{"key":"2022031302295616700_B21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/000992288202100806","article-title":"Adolescent self-assessment of sexual maturation: reassessment and evaluation in a mixed ethnic urban population","volume":"21","author":"Neinstein","year":"1982","journal-title":"Clin Pediatr (Phila)"},{"key":"2022031302295616700_B22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2022031302295616700_B23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1067\/mpd.2003.205","article-title":"American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood","volume":"142","author":"Kavey","year":"2003","journal-title":"J Pediatr"},{"key":"2022031302295616700_B24","first-page":"S168","article-title":"Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2008","journal-title":"Can J Diabetes"},{"key":"2022031302295616700_B25","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1210\/jc.2008-0801","article-title":"Reproducibility of the oral glucose tolerance test in overweight children","volume":"93","author":"Libman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031302295616700_B26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"International Expert Committee","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031302295616700_B27","first-page":"947","article-title":"Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?","volume-title":"J Pediatr","author":"Lee","year":"2011"},{"key":"2022031302295616700_B28","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2337\/dc10-1984","article-title":"Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents","volume":"34","author":"Nowicka","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/35\/4\/711\/611538\/711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/35\/4\/711\/611538\/711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T06:44:12Z","timestamp":1647153852000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/35\/4\/711\/38378\/Screening-for-Dysglycemia-in-Overweight-Youth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,13]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,3,13]]},"published-print":{"date-parts":[[2012,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc11-1659","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,13]]}}}